Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roche announces that its Tina-quant lipoprotein Lp RxDx test has been designated a breakthrough device by the U.S. FDA to identify patients likely to benefit from an innovative Lp-lowering therapy...
The deal is the second acquisition for CG Life this year, following the addition of Toolhouse in March.
Press release - ABNewswire - Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets - published on openPR.com
In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.
The new Scottish Brain Sciences (SBS) laboratory at the University of St Andrews Eden Campus innovation hub and multinational healthcare company Roche Diagnostics, are collaborating in a study that will bring the first blood tests to Scotland for the detection of Alzheimer’s disease in its early stages. Click to read more...